|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kelley JR and Duggan JM: Gastric cancer
epidemiology and risk factors. J Clin Epidemiol. 56:1–9. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Crew KD and Neugut AI: Epidemiology of
gastric cancer. World J Gastroenterol. 12:354–362. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mendell JT: MicroRNAs: Critical regulators
of development, cellular physiology and malignancy. Cell Cycle.
4:1179–1184. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jansson MD and Lund AH: MicroRNA and
cancer. Mol Oncol. 6:590–610. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mohammadi-Yeganeh S, Paryan M, Arefian E,
Vasei M, Ghanbarian H, Mahdian R, Karimipoor M and Soleimani M:
MicroRNA-340 inhibits the migration, invasion, and metastasis of
breast cancer cells by targeting Wnt pathway. Tumour Biol. Jan
12–2016.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen CP, Sun ZL, Lu X, Wu WX, Guo WL, Lu
JJ, Han C, Huang JQ and Fang Y: miR-340 suppresses cell migration
and invasion by targeting MYO10 in breast cancer. Oncol Rep.
35:709–716. 2016.
|
|
10
|
Huang K, Tang Y, He L and Dai Y:
MicroRNA-340 inhibits prostate cancer cell proliferation and
metastasis by targeting the MDM2-p53 pathway. Oncol Rep.
35:887–895. 2016.PubMed/NCBI
|
|
11
|
Wei P, Qiao B, Li Q, Han X, Zhang H, Huo Q
and Sun J: microRNA-340 suppresses tumorigenic potential of
prostate cancer cells by targeting high-mobility group
nucleosome-binding domain 5. DNA Cell Biol. 35:33–43. 2016.
View Article : Google Scholar
|
|
12
|
Yan S, Jiang H, Fang S, Yin F, Wang Z, Jia
Y, Sun X, Wu S, Jiang T and Mao A: MicroRNA-340 inhibits esophageal
cancer cell growth and invasion by targeting phosphoserine
aminotransferase 1. Cell Physiol Biochem. 37:375–386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shi L, Chen Z-G, Wu LL, Zheng JJ, Yang JR,
Chen XF, Chen ZQ, Liu CL, Chi SY, Zheng JY, et al: miR-340 reverses
cisplatin resistance of hepatocellular carcinoma cell lines by
targeting Nrf2-dependent antioxidant pathway. Asian Pac J Cancer
Prev. 15:10439–10444. 2014. View Article : Google Scholar
|
|
14
|
Yamashita D, Kondo T, Ohue S, Takahashi H,
Ishikawa M, Matoba R, Suehiro S, Kohno S, Harada H, Tanaka J, et
al: miR340 suppresses the stem-like cell function of
glioma-initiating cells by targeting tissue plasminogen activator.
Cancer Res. 75:1123–1133. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guo J, Miao Y, Xiao B, Huan R, Jiang Z,
Meng D and Wang Y: Differential expression of microRNA species in
human gastric cancer versus non-tumorous tissues. J Gastroenterol
Hepatol. 24:652–657. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yao Y, Suo AL, Li ZF, Liu LY, Tian T, Ni
L, Zhang WG, Nan KJ, Song TS and Huang C: MicroRNA profiling of
human gastric cancer. Mol Med Rep. 2:963–970. 2009.PubMed/NCBI
|
|
17
|
Hou X and Qiao H: Effect of miR-340 on
gastric cancer cell proliferation and apoptosis. Int J Clin Exp
Pathol. 8:13108–13113. 2015.
|
|
18
|
Petrocca F, Pilozzi E, Rapazzotti M,
Aurello P, Mercantini P, Volinia S, Ruco LP, Croce CM and Vecchione
A: MicroRNAs deregulation in gastric cancer. Cancer Res. 66:1338.
2006.
|
|
19
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bates S, Rowan S and Vousden KH:
Characterisation of human cyclin G1 and G2: DNA damage inducible
genes. Oncogene. 13:1103–1109. 1996.PubMed/NCBI
|
|
21
|
Shi W, Yu K, Wu G and Zhang H: Expression
of CCNG2 in gastric carcinoma and its relationship with prognosis.
Chin J Cell Biol. 33:994–997. 2011.
|
|
22
|
Sun GG, Hu WN, Cui DW and Zhang J:
Decreased expression of CCNG2 is significantly linked to the
malignant transformation of gastric carcinoma. Tumour Biol.
35:2631–2639. 2014. View Article : Google Scholar
|
